Skip to content

ABCAction.News

  • USA
  • Business
  • Entertain
  • Health
  • Science
  • Sports
  • Tech
  • World

ABCAction.News

  • USA
  • Business
  • Entertain
  • Health
  • Science
  • Sports
  • Tech
  • World

Biotechnology

Synairgen inhaled interferon for COVID-19 improves short, harmless version of virus entry point: study

Synairgen inhaled interferon for COVID-19 improves short, harmless version of virus entry point: study

Covid kills nearly 3,000 in US, CDC warns of “intense event” by Capitol riots

Covid kills nearly 3,000 in US, CDC warns of “intense event” by Capitol riots

White House Covid Working Group Warns of Possible New Spread of “US Variant”

White House Covid Working Group Warns of Possible New Spread of “US Variant”

The head of the FDA encourages states to open fire on more people

The head of the FDA encourages states to open fire on more people

Sarepta stock falls in low outcomes for gene therapy

Sarepta stock falls in low outcomes for gene therapy

The United States reports more than 4,000 deaths from Covid for the first time as the outbreak worsens

The United States reports more than 4,000 deaths from Covid for the first time as the outbreak worsens

Canada criticized for launching Covid-19 vaccines

Canada criticized for launching Covid-19 vaccines

AstraZeneca PLC ADR falls on Thursday, with a lower performance on the market

AstraZeneca PLC ADR falls on Thursday, with a lower performance on the market

Sarepta stock falls more than 50% after mixed results from the drug study

Sarepta stock falls more than 50% after mixed results from the drug study

Sinovac’s Covid-19 vaccine is 78% effective in Brazil’s final phase trials

Sinovac’s Covid-19 vaccine is 78% effective in Brazil’s final phase trials

Older posts
Newer posts
← Previous Page1 … Page32 Page33 Page34 … Page42 Next →

footer

  • About
  • Contact Us
  • DMCA
  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Sitemap
  • Sitemap-News
© 2025 ABCAction.News